Literature DB >> 23696418

Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice.

Emeline Aufradet1, Geneviève DeSouza, Vanessa Bourgeaux, Amine Bessaad, Yannick Campion, Emmanuelle Canet-Soulas, Vincent Pialoux, Erica N Chirico, Anne-Marie Chevrier, Yann Godfrin, Cyril Martin.   

Abstract

In sickle cell disease, the factors involved in vasoocclusive crisis (VOC) include the sickling of red blood cells (RBC), abnormal blood rheology, inflammation, vascular adhesion, oxidative stress, coagulation, and vascular tone modulation. The aim of this study was to further characterize the molecular response of some factors involved in VOC by inducing a hypoxia/reoxygenation stress in sickle SAD mice. Results show that a hypoxia/reoxygenation stress in SAD mice can induce: (i) a decrease in reticulocytes count, and mean corpuscular volume along with an increase in lactate dehydrogenase (p = 0.07) and sickled cell proportion; (ii) a significant increase in lung VCAM-1, ICAM-1, IL-1β, ET-1, eNOS, and TF mRNA associated with an increase in VCAM-1 expression on lung endothelium; (iii) a rise in cardiac oxidative stress with increased lipid oxidation and decreased anti-oxidant enzyme activities, and (iv) an increase in plasma TNF-α and IL-6 and a decrease in plasma ET-1. In SAD mice, hypoxia/reoxygenation stress induces hemolysis that, together with oxidative stress, inflammation, vascular adhesion, and coagulation, may induce vascular occlusion and consequently RBC sickling. The present results give the kinetics of VOC molecular markers in SAD mice which may aid in testing the efficiency of new therapeutic processes against VOC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23696418     DOI: 10.3233/CH-131735

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  6 in total

Review 1.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 2.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

Review 3.  Sickle cell vaso-occlusion: The dialectic between red cells and white cells.

Authors:  Nicola Conran; Stephen H Embury
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-01

4.  Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease.

Authors:  Hongyu Wu; Mikhail Bogdanov; Yujin Zhang; Kaiqi Sun; Shushan Zhao; Anren Song; Renna Luo; Nicholas F Parchim; Hong Liu; Aji Huang; Morayo G Adebiyi; Jianping Jin; Danny C Alexander; Michael V Milburn; Modupe Idowu; Harinder S Juneja; Rodney E Kellems; William Dowhan; Yang Xia
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

Review 5.  Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.

Authors:  Maria A Lizarralde-Iragorri; Arun S Shet
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

6.  Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia.

Authors:  Xavier Waltz; Marc Romana; Marie-Dominique Hardy-Dessources; Yann Lamarre; Lydia Divialle-Doumdo; Marie Petras; Vanessa Tarer; Régine Hierso; Kizzy-Clara Baltyde; Benoît Tressières; Marie-Laure Lalanne-Mistrih; Fréderic Maillard; Olivier Hue; Maryse Etienne-Julan; Philippe Connes
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.